Data detailed in 'Influence of pretransplantation restrictive lung disease on allogeneic hematopoietic cell transplantation outcomes' have been presented. "We conducted a 15-year retrospective cohort study to determine the prevalence of restrictive lung disease before allogeneic hematopoietic cell transplantation (HCT), and to assess whether this was a risk factor for poor outcomes. A total of 2545 patients were eligible for the analysis," scientists writing in the journal Biology of Blood and Marrow Transplantation report (see also Lung Disease).
"Restrictive lung disease was defined as a total lung capacity (TLC) <80% of predicted normal. Chest x-rays and /or computed …

Комментариев нет:
Отправить комментарий